Advertisement

Therapeutic plasma exchange (TPE) and blood products – Implications for longevity and disease

      People worldwide are living longer. According to the World Health Organization, by 2050 the world’s population aged 60 or older is expected to total 2 billion, up from 900 million in 2015. Although longer life brings personal, familial, and societal opportunities, older age is associated with a number of physical and mental disorders. Age related diseases are the leading cause of death and healthcare costs. Reducing the rate of aging would have enormous medical and financial benefits.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Conboy I.M.
        • Conboy M.J.
        • Wagers A.J.
        • Ginna Er
        • Weismann I.L.
        • Rando T.A.
        Rejuvenation of aged progenitor cells by exposure to a young systemic environment.
        Nature. 2005; 433: 750-754https://doi.org/10.1038/nature03260
        • Conboy I.M.
        • Rando T.A.
        Aging, stem cells and tissue regeneration: lessons from muscle.
        Cell Cycle. 2005; 4: 407-410https://doi.org/10.4161/cc4.3.1518
        • Conboy M.J.
        • Conboy I.M.
        • Rando T.A.
        Heterochronic parabiosis: historical perspective and methodological considerations for studies of aging and longevity.
        Aging Cell. 2013; 12: 525-530
        • Conboy I.M.
        • Rando T.A.
        Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches.
        Cell Cycle. 2012; 11: 2260-2267
        • Conboy I.M.
        • Conboy I.M.J.
        • Rebo J.
        Systemic problems: a perspective on stem cell aging and rejuvenation.
        Aging (Albany NY). 2015; 7: 754-765
        • Carlson M.E.
        • Silva H.S.
        • Conboy I.M.
        Aging of signal transduction pathways and pathology.
        Exp Cell Res. 2008; 314: 1951-1961
        • Yousef H.
        • Morgenthaler A.
        • Schlesinger C.
        • Bugaj L.
        • Conboy I.M.
        • Schaffer D.V.
        Age-associated increase in BMP signaling inhibits hippocampal neurogenesis.
        Stem Cells. 2015; 33: 1577-1588https://doi.org/10.1002/stem.1943
        • Yousef H.
        • Conboy M.J.
        • Morgenthaler A.
        • Schlesinger C.
        • Bugaj L.
        • Paliwal P.
        • et al.
        Systemic attenuation of the TGFβ pathway by a single drug simultaneously rejuvenates hippocampal neurogenesis and myogenesis in the same old mammal.
        Oncotarget. 2015; 6: 11959-11978https://doi.org/10.18632/oncotarget.3851
        • Katsimpardi L.
        • Litterman N.K.
        • Schein P.A.
        • Miller C.M.
        • Loffredo F.S.
        • Wojtkiewicz G.R.
        • et al.
        Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors.
        Science (80-). 2014; 344: 630-634https://doi.org/10.1126/science.1251141
        • Smith L.K.
        • He Y.
        • Park J.S.
        • Bieri G.
        • Snethlage C.E.
        • Lin K.
        • et al.
        β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis.
        Nat Med. 2015; 21: 932-937
        • Castellano J.M.
        • Mosher K.I.
        • Abbey R.J.
        • McBride A.A.
        • James M.L.
        • Berdnik D.
        • et al.
        Human umbilical cord plasma proteins revitalize hippocampal function in aged mice.
        Nature. 2017; 544: 488-492https://doi.org/10.1038/nature22067
        • Yusef H.
        • Czupalla C.J.
        • Lee D.
        • Chen M.B.
        • Burke A.N.
        • Zera K.A.
        • et al.
        Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1.
        Nat Med. 2019; 25: 988-1000https://doi.org/10.1038/s4159-019-0440-4
        • Brun C.E.
        • Rudnicki M.A.
        GDF11 and the mythical fountain of youth.
        Cell Metab. 2015; 22: 54-56https://doi.org/10.1016/j-cmet.2015.05.009
        • Sha S.J.
        • Deutsch G.K.
        • Tian L.
        • Richardson K.
        • Coburn M.
        • Gaudioso J.L.
        • et al.
        Safety, tolerability, and feasibility of young plasma infusion in the plasma for Alzheimer symptom amelioration study: a randomized clinical trial.
        JAMA Neurol. 2019; 76: 35-40https://doi.org/10.1001/jammaneurol.2018.3288
        • Kaiser J.
        Antiaging trial using young blood stirs concerns.
        Science. 2016; 353: 527-528https://doi.org/10.1126/science.353.6299.527
        • Mehdipour M.
        • Skinner C.
        • Wong N.
        • Lieb M.
        • Liu C.
        • Etienne J.
        • et al.
        Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin.
        Aging (Albany NY). 2020; 12: 8790-8819https://doi.org/10.18632/aging.103418
        • Kiprov D.D.
        Intermittent heterochronic plasma exchange as a modality for delaying cellular senescence—a hypothesis.
        J Clin Apher. 2013; 28: 387-389https://doi.org/10.1002/jca.21286
        • De Magalaes J.P.
        • Stevens M.
        • Thornton D.
        The business of anti-aging science.
        Trends Biotechnol. 2017; 35 (2017 the Authors): 1062-1070https://doi.org/10.1016/j.tibtech.2017.07.004